ÂÜÀòÂÒÂ×

Leonard Wossnig serves as Chief Technology Officer at LabGenius since November 2022, leading advancements in antibody discovery through synthetic biology, robotic automation, and machine learning for immunotherapy development. Additionally, Leonard holds positions as Fellow of the Royal Society of Biology, Scientific Advisor at Shift Bioscience, and Venture Network Partner at 2048 Ventures. As an Honorary Research Fellow in Computer Science at UCL, Leonard previously worked as Vice President of Artificial Intelligence at Odyssey Therapeutics and co-founded Rahko. Leonard's academic credentials include a PhD in Theoretical Computer Science from UCL, a Master's degree in Physics from ETH Zürich, and a Bachelor's degree in Physics from the University of Augsburg.